Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiplatelet and Anticoagulant Drugs for Prevention of Restenosis/reocclusion Following Peripheral Endovascular Treatment." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438050/all/repview. Accessed 27 April 2024.
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438050/all/repview. Accessed April 27, 2024.
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438050/all/repview
Antiplatelet and Anticoagulant Drugs for Prevention of Restenosis/reocclusion Following Peripheral Endovascular Treatment [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438050/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
ID - 438050
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438050/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -